Neudle.com: "methotrexate"

Differential
(Click to cross reference)

abducens nerve paralysis

acoustic nerve

advances in neurology

adverse drug reaction

alcohol intolerance

alkylating agents

altered states of consciousness

alternating hemiplegia

alternating hemiplegia of childhood

antimetabolite

antiphospholipid antibodies

antiphospholipid antibody syndrome

aphasia

apraxia, constructional

autonomic dysfunction

blood dyscrasias, neurologic findings with

bone marrow transplantation

brain biopsy

brain biopsy, stereotaxic

CAT scan, disappearing lesion on

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, hyperattenuation

central nervous system, infection of

central nervous system, infection, cancer patient

central pontine myelinolysis

cerebral cortical atrophy

cerebral edema

cerebral edema, cytotoxic

cerebral infarction

cerebral ischemia

cerebral vasculature, calcification

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, cytology

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, flow cytometry

cerebrospinal fluid, pressure low

cerebrovascular accident

cerebrovascular disease

Charcot-Marie-Tooth

chemotherapy, CNS treatment and complications with

Clinical Pathologic Conference(C.P.C.)

cognition

collagen vascular disease

coma

complications

confusion

conjugate gaze, forced

cop 1

corpus callosum

corpus callosum, lesion of

cost effectiveness

cranial nerve enhancement

cranial nerves

cranial neuropathy

cranial neuropathy, multiple

C-reactive protein, elevated

dermatomyositis, childhood

diplopia

disorientation

disseminated intravascular coagulation(DIC)

distal muscle weakness

drug induced neurologic disorders

dural sinus thrombosis

electroencephalogram, abnormalities of

electromyogram

encephalopathy

encephalopathy, acute

etanercept

extraocular muscle enlargement

extraocular muscle lesion

eye, pain in

facial nerve palsy

facial nerve palsy, bilateral

fungal infection, CNS

gadolinium

gait disorder

gammaglobulin therapy, intravenous

glioma

granulomatosis with polyangiitis

Guillain Barre syndrome

hallucination

hallucination, visual

hypertrophic spinal pachymeningitis

hyponatremia

iatrogenic neurologic disorders

imbalance

immunologic disease

immunosuppression

immunosuppressive agents

immunotherapy

impotence

inappropriate antidiuretic(A.D.H.)hormone

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

inattention

inclusion bodies, intracytopasmic

inclusion bodies, intranuclear

inclusion body myositis

infantile spasm

infliximab

intellectual deterioration

interferon

interferon beta 1-a

interferon beta 1-b

intracerebral hemorrhage

intrathecal chemotherapy

intrathecal treatment of meningitis

intraventricular chemotherapy

isoniazid

jaw pain

Korsakoff's psychosis

lateropulsion

learning disability, in children

lethargy

leukemia

leukemia, neurologic findings assoc.with

leukemia, prophylactic treatment of CNS

leukocytosis

leukodystrophy

leukoencephalopathy

leukoencephalopathy, toxic

leukostasis

level of consciousness, decreased

life expectancy

lymphoma

lymphoma involving CNS

lymphoma, meningeal

lymphoma, primary of CNS

MATILDE regimen

medullary streaks

melanoma, malignant

memory, impairment of

meningeal enhancement

meningismus

meningitis

meningitis, aseptic

meningitis, bacterial

meningitis, basilar

meningitis, carcinomatous

meningitis, leukemic

meningoencephalopathy

mental status, abnormal

methotrexate

methylhydrazine derivatives

microangiopathy, brain

microinfarcts

mitoxantrone

monoamine oxidase inhibitors

monoclonal antibodies

MRI, contrast enhanced

MRI, diffusion weighted

MRI, disappearing lesion on

multiple sclerosis, chronic progressive

multiple sclerosis, relapsing

multiple sclerosis, treatment of

muscle biopsy

muscle biopsy, extraocular

muscle pain

muscle stiffness

muscle weakness

muscular dystrophy, facioscapulohumeral

mutism

myasthenia gravis

myasthenia gravis, treatment of

mycophenolate

myelin basic protein

myelopathy

myelopathy, ascending

myopathy

myopathy, distal, vacuolar

myopathy, necrotizing

myopathy, steroid induced

myopathy, steroid responsive

necrotizing vasculitis

negative

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS-prophylactic chemotherapy of

neoplasm, metastatic to CNS-prophylactic irradiation of

neoplasm, metastatic to CNS-treatment of

neoplasm, primary of CNS

neoplasm, primary of CNS-recurrent

neoplasm, primary of CNS-surgical treatment of

neoplasm, primary of CNS-survival

neoplasm, primary of CNS-treatment of

neuroaxonal dystrophy

neurologic complications of, systemic cancer

neurologic disease, diagnoses of

neurologic examination, focal

neuropathology

neuropathy

neuropathy, peripheral

old age, neurology of

Ommaya reservoir

ophthalmoplegia

opportunistic infection

opportunistic infection, CNS

optic neuropathy

orbit, biopsy

orbit, inflammation in

orbit, lesions of

orbital apex

orthostatic hypotension

pleocytosis of cerebrospinal fluid

polymyalgia rheumatica

polymyositis

polyneuropathy

polyneuropathy, chronic inflammatory demyelinating

polyneuropathy, lymphomatous

polyradiculoneuropathy

posterior leukoencephalopathy syndrome

pregnancy, neurologic complications in

procarbazine

prognosis

progressive neurologic disorder

proptosis

proptosis, unilateral

psychological testing

radiation encephalopathy, delayed

radiation necrosis

radiation therapy, CNS treatment and complications with

radiation therapy, total body

radiculopathy

rash

reading disorder, acquired

rheumatoid arthritis, neurologic complications of

rheumatoid pachymeningitis

risk factors

rituximab

safety

salivary gland enlargement

sedimentation rate, elevated

spinal cord, compression of

spinal cord, lesion of

splenium of corpus callosum

spongy degeneration of brain

stem cell transplantation

steroid

steroid therapy, CNS treatment and complications with

superior sagittal sinus thrombosis

symmetric brain lesions

temporal artery, biopsy

theophylline

tinnitus

toxic encephalopathy

transient ischemic attack

transient neurologic deficit

treatment of neurologic disorder

tremor

tremor, leg

tumor necrosis factor inhibitor

vincristine neurotoxicity

visual field defect

visual loss

visuospatial disturbance

vocal cord paralysis

walking, difficulty with

Showing articles 0 to 50 of 80 Next >>

A 59-Year-Old Woman Presenting with Diplopia, Dysarthria, Right-sided Weakness, and Encephalopathy
Neurol 97:e859-e864, Manzano, G.S.,et al, 2021

Management and Outcome of Primary CNS Lymphoma in the Modern Era
Neurol 94:e1027-e1039, Houillier, C., et al, 2020

Clinicopathologic Conference, Granulomatosis with Polyangiitis
NEJM 379:2452-2461, Case 39-2018, 2018

Polymyalgia Rheumatica and Giant Cell Arteritis
JAMA 315:2442-2458, Buttgereit, F.,et al, 2016

A Randomized Controlled Trial of Methotrexate for Patients with Generalized Myasthenia Gravis
Neurol 87:57-64, Pasnoor, M.,et al, 2016

Treatment of Neurosarcoidosis
Neurol 87:2517-2521, Bitoun, S.,et al, 2016

MATILDE Chemotherapy Regimen for Primary CNS Lymphoma
Neurol 82:1370-1373, Ferreri, A.J.M.,et al, 2014

Progressive Visuospatial Problems in a 71-Year-Old Man
Neurol 83:e6-e10, Symmonds, M.,et al, 2014

Long-Term Cognitive Function, Neuroimaging and Quality of Life in Primary CNS Lymphoma
Neurol 81:84-92, Doolittle, N.,et al, 2013

Primary Leptomeningeal Lymphoma
Neurol 81:1690-1696, Taylor, J.W.,et al, 2013

Treatment of Behcets Disease
UpToDate, Jan, Smith, E.L. & Yazici, Y., 2012

Primary Central Nervous System Lymphoma
Arch Neurol 67:291-297, Gerstner,E.R. &Batchelor,T.T., 2010

Long-Term Survival with Favorable Cognitive Outcome After Chemotherapy in Primary Central Nervous System Lymphoma
Ann Neurol 67:182-189, Juergens,A.,et al, 2010

Treatment and Prognosis of Primary Central Nervous System Lymphoma
Up to Date Sept 2010, Hochberg,F.H.,et al, 2010

High-Dose Cytarabine Plus High-Dose Methotrexate Versus High-Dose Methotrexate Alone in Patients with Primary CNS Lymphoma: A Randomised Phase 2 Trial
Lancet 374:1512-1520, 1477, Ferreri,A.,et al, 2009

Clinical and Radiological Characteristics of Methotrexate-Induced Acute Encephalopathy in Pediatric Patients with Cancer
Ann Oncol 19:178-184, Inaba, H.,et al, 2008

Long-Term Outcome in PCNSL Patients Treated with High-Dose Methotrexate and Deferred Radiation
Neurol 70:401-402, Gerstner,E.R.,et al, 2008

Juvenile Dermatomyositis and Other Idiopathic Inflammatory Myopathies of Childhood
Lancet 371:2201-2212, Feldman,B.M.,et al., 2008

Delayed Leukoencephalopathy with Stroke-Like Presentation in Chemotherapy Recipients
JNNP 79:535-539, Baehring,J.M. &Fulbright,R.K., 2008

Clinical Manifestations and Treatment of Rheumatoid Pachymeningitis
Neurol 68:1079-1080, Starosta,M.A. &Brandwein,S.R., 2007

Salvage Whole Brain Radiotherapy for Recurrent or Refractory Primary CNS Lymphoma
Neurol 69:1178-1182, Hottinger,A.F.,et al, 2007

Age and High-Dose Methotrexate are Associated to Clinical Acute Encephalopathy in FRALLE 93 Trial for Acute Lymphoblastic Leukemia in Children
Leukemia 21:238-247, Dufourg, M.N.,et al, 2007

Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy with Methotrexate
JNNP 77:544-547, Fialho,D.,et al, 2006

Update on Primary Central Nervous System Lymphoma
Curr Opin Neurol 18:645-653, Plotkin,S.R., 2005

Clinicopath Conf., Primary Diffuse Large-B-Cell Lymphoma of the Brain
NEJM 352:185-194, Case 1-2005, 2005

Prevalence of Leukoencephalopathy in Children Treated for Acute Lymphoblastic Leukemia with High-Dose Methotrexate
AJNR 26:1263-1269, Reddick,W.E.,et al, 2005

NOA-03 Trial of High-Dose Methotrexate in Primary Central Nervous System Lymphoma:Final Report
Ann Neurol 57:843-847, Herrlinger,W.,et al, 2005

Diffusion-Weighted MR Imaging of Early Methotrexate-Related Neurotoxicity in Children
AJNR 26:1686-1689, Fisher,M.J.,et al, 2005

Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004

Acute Methotrexate Neurotoxicity: Findings on Diffusion-Weighted Imaging and Correlation with Clinical Outcome
AJNR 25:1688-1695, Rollins,N.,et al, 2004

Treatment of Primary CNS Lymphoma with Methotrexate and Deferred Radiotherapy: A Report of NABTT 96-07
J Clin Oncol 21:1044-1049, Batchelor,T.,et al, 2003

Biochemical And Clinical Aspects of Methotrexate Neurotoxicity
Chemotherapy 49:92-104, Vezmar,S.,et al, 2003

Neurotoxocity of Intrathecal Methotrexate: MR Imaging Findings
AJNR 24:1887-1890, Sandoval,C.,et al, 2003

An Open-Label Trial of Combination Therapy With Interferon B-1a and Oral Methotrexate in MS
Neurol 58:314-317, Calabresi,P.A.,et al, 2002

A Multicenter Study of Treatment of Primary CNS Lymphoma
Neurol 58:1513-1520, Ferreri,A.J.M.,et al, 2002

German Cancer Society Neuro-Oncology Working Group NOA-03 Multicenter Trial of Single-Agent High-Dose Methotrexate for Primary Central Nervous System Lymphoma
Ann Neurol 51:247-252, Herrlinger,U.,et al, 2002

Systematic Review of Immunomodulatory Drugs for the Treatment of People with Multiple Sclerosis: Is There Good Quality Evidence on Effectiveness and Cost?
JNNP 70:574-579, Bryan,J.,et al, 2001

Hypertrophic Chronic Pachymeningitis as a Localized Immune Process in the Craniocervical Region
Neurol 56:107-109, Boller,B.,et al, 2001

Chorea and Antiphospholipid Antibodies: Treatment with Methotrexate
Neurol 56:137-138, Paus,S.,et al, 2001

Diagnosis and Management of Neurological Sarcoidosis
Arch Int Med 157:1864-1868, Lower,E.E.,et al, 1997

Treatment of Inflammatory Myopathies
Muscle & Nerve 20:651-664997., Mastaglia,F.L.,et al, 1997

Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997

Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996

Therapy of Primary CNS Lymphoma with Methotrexate-Based Chemotherapy and Deferred Radiotherapy:Prelimary Results
Neurol 46:1757-1759, Cher,L.,et al, 1996

Low-Dose Oral Methotrexate in Chronic Progressive Multiple Sclerosis:Analyses of Serial MRIs
Neurol 47:1153-1157, Goodkin,D.E.,et al, 1996

Low-Dose (7. 5mg) Oral Methotrexate Reduces the Rate of Progression in Chronic Progressive Multiple Sclerosis
Ann Nuerol 37:30-40, 51995., Goodkin,D.E.,et al, 1995

Aminophylline for Methotrexate-Induced Neurotoxicity
Lancet 345:544-547, Bernini,J.C.,et al, 1995

Drug Therapy of Idiopathic Inflammatory Myopathies:Response to Prednisone Azathioprine, & Methotrexate
Am J Med 94:379-387, Joffe,M.M.,et al, 1993

The Treatment of Inclusion Body Myositis:A Retrospective Review & Random, Prospective Trial of Immunosupp Therapy
Medicine 72:225-235, Leff,R.L.,et al, 1993

Showing articles 0 to 50 of 80 Next >>